News | July 15, 2014

Sun Nuclear Announces Acquisition Agreement with Gammex Inc.

July 15, 2014 — Sun Nuclear Corp. announced its intended acquisition of Gammex Inc., which became effective July 2. The acquisition combines two complementary product lines within the radiation oncology marketplace, and adds diagnostic radiology quality assurance (QA) capability to Sun Nuclear's therapeutic radiation oncology QA and dosimetry position.

"I am excited to see these two companies combine because of their deep synergies," said Margaret Lescrenier, president of Gammex Inc. "We started Gammex in 1969 and have been pioneers in radiation oncology and diagnostic products for over 40 years. We see a promising future for continued innovation and growth of the Gammex product line under the new leadership of SNC."

"We are very excited to bring Gammex into the Sun Nuclear family," says Jeff Simon, CEO of Sun Nuclear. "Gammex has a long history of meaningful innovation and technical expertise that fits perfectly with Sun Nuclear's core values and mission. We believe Gammex is a company of great opportunity, and look forward to providing the market leadership in quality assurance and patient safety that Sun Nuclear is known for today, and to continue Gammex's rich history of innovation. We are also excited to make this investment in Middleton (Madison) Wisconsin, a recognized world leader in the medical physics and cancer care industry, and home to the University of Wisconsin."

For more information: www.sunnuclear.com, www.gammex.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...